Evidence map›Paper›PMID 21221598›Full record

ArticleHeart and vessels2011

Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings.

Tatsuhiko Hirota, Atsuko Nonaka, Akiko Matsushita, Naoto Uchida, Kohji Ohki, Masanori Asakura, Masafumi Kitakaze

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Antiinflammatory peptides: current knowledge and promising prospects.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tatsuhiko HirotaMicrobiology and Fermentation Laboratory, Calpis Co., Ltd., 5-11-10 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-0206, Japan. tatsuhiko.hirota@calpis.co.jp
Atsuko Nonaka
Akiko Matsushita
Naoto Uchida
Kohji Ohki
Masanori Asakura
Masafumi Kitakaze
National Cerebral and Cardiovascular Center · JPAzabu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Milk casein-derived tripeptides, valyl prolyl proline (VPP), and isoleucyl prolyl proline (IPP) inhibit angiotensin-converting enzyme (ACE) and both fermented milk and proteolytic hydrolysates of milk casein containing these peptides exert blood pressure-lowering effects in animals and humans. On the top of these results, we have recently reported that the hydrolysate of milk casein containing both VPP and IPP improved the vascular endothelial function of subjects with stage I hypertension, enforcing us to elucidate the mechanism of the improvement of endothelial dysfunction by these peptides. For this purpose, we examined the effect of VPP and IPP on induction of nitric oxide (NO) production using cultured vascular endothelial cells and isolated arterial vessels. When both VPP and IPP were added to the medium of cultured endothelial cells at final concentrations of more than 100 nmol/l, the NO(x) (NO(2) and NO(3)) concentration in the medium was significantly higher than that of the control. Moreover, both VPP and IPP induced endothelium-dependent relaxation of isolated aortic rings, and these effects were inhibited by NO synthase inhibitors, K channel inhibitors, and bradykinin B2 receptor antagonists. These lines of results suggested that both VPP and IPP induced production of vasodilative substances including NO.

Indexed as

AnimalsAorta, ThoracicBradykinin B2 Receptor AntagonistsCells, CulturedDose-Response Relationship, DrugEnzyme InhibitorsHumansHuman Umbilical Vein Endothelial CellsMaleNitric OxideNitric Oxide SynthaseOligopeptidesPeptidyl-Dipeptidase APotassium Channel BlockersRatsRats, WistarBradykinin B2 Receptor AntagonistsEnzyme Inhibitorsisoleucyl-prolyl-prolineNitric OxideNitric Oxide SynthaseOligopeptidesPeptidyl-Dipeptidase APotassium Channel BlockersReceptor, Bradykinin B2valyl-prolyl-prolineVasodilator Agents

Identifiers

PMID21221598
OpenAlexW2048603840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.